European Biosimilars Trade Group Appoints New Leadership Team
This article was originally published in SRA
Executive Summary
The European Biosimilar medicines Group (EBG) has elected Carol Lynch as Chair of the overall sector group and Klaus Martin as Chair of the EGB's market access group1.